Table 4.
ANOVA P-value of treatment groups on d 10, 24, and 35 (iterations = 1000).
| CON | SA | BMD | SA+PP | |
|---|---|---|---|---|
| CONa-D10 | - | - | - | - |
| CON-D24 | - | - | - | - |
| CON-D35 | - | - | - | - |
| SAb-D10 | 0.003 | - | - | - |
| SA-D24 | 0.003 | - | - | - |
| SA-D35 | 0.01 | - | - | - |
| BMDc-D10 | 0.40 | 0.16 | - | - |
| BMD-D24 | 0.50 | 0.12 | - | - |
| BMD-D35 | 0.008 | 0.06 | - | - |
| SA-PPd-D10 | 0.15 | 0.005 | 0.26 | - |
| SA-PP-D24 | 0.12 | 0.015 | 0.86 | - |
| SA-PP-D35 | 0.06 | 0.31 | 0.04 | - |
a
CON is control treatment.
b
SA is salinomycin treatment.
c
BMD is bacitracin methylene disalicylate.
d
SA-PP is salinomycin plus penicillin G potassium.